Properties
Description
Eplivanserin inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets 5-HT2A receptor, 5-HT2A receptor, and 5-HT2C receptor.
Molecular Formula
C19H21FN2O2
Targets
5-HT2A receptor: 5.8 nM (IC50, in rat cortical membrane); 5-HT2A receptor: 1.14 nM; 5-HT2C receptor: 120 nM
Applications
Eplivanserin can be used for its ability to promote sleep induction and improve sleep quality in patients with insomnia.